Hikma Pharmaceuticals Plc Net Profit Margin 2016-2018 | HKMPF

Current and historical net profit margin for Hikma Pharmaceuticals Plc (HKMPF) from 2016 to 2018. Net profit margin can be defined as net Income as a portion of total sales revenue. Hikma Pharmaceuticals Plc net profit margin for the three months ending December 31, 2018 was .
Hikma Pharmaceuticals Plc Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.986B $2.070B
Hikma Pharmaceuticals PLC develops, manufactures and markets pharmaceutical products. Its brand portfolio includes branded, injectables and generic. Branded segment offers dosage forms and strengths in the anti-infective, cardiovascular, diabetes, central nervous system, oncology and respiratory. Injectables segment offers dosage for CNS, controlled substances, anti-infective, cardiovascular and oncology in form of liquid, semi-liquid and powdered form. Generics segment offers dosage for therapeutic including analgesic, anti-infective, anti-inflammatory, cardiovascular, CNS, respiratory and hormonal. Hikma Pharmaceuticals PLC is based in London, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.527B 10.04
Zoetis (ZTS) United States $57.408B 34.34
Astellas Pharma (ALPMY) Japan $32.261B 16.11
Eisai (ESALY) Japan $20.266B 39.08
UCB SA (UCBJF) Belgium $15.697B 0.00
Grifols, S.A (GRFS) Spain $15.422B 20.21
Merck (MKGAF) Germany $14.921B 20.36
Neurocrine Biosciences (NBIX) United States $10.834B 511.48
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $9.341B 0.00
Ionis Pharmaceuticals (IONS) United States $9.028B 18.28
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.285B 10.58
Sage Therapeutics (SAGE) United States $7.761B 0.00
Catalent (CTLT) United States $7.514B 30.57
Arrowhead Pharmaceuticals (ARWR) United States $6.571B 99.51
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.881B 17.55
United Therapeutics (UTHR) United States $3.915B 0.00
FibroGen (FGEN) United States $3.860B 113.44
Taro Pharmaceutical Industries (TARO) Israel $3.635B 13.29
Nektar Therapeutics (NKTR) United States $3.423B 0.00
Evotec AG (EVTCY) Germany $3.226B 52.78
PTC Therapeutics (PTCT) United States $3.079B 0.00
Heron Therapeutics (HRTX) United States $2.396B 0.00
Xencor (XNCR) United States $2.245B 68.24
Portola Pharmaceuticals (PTLA) United States $2.163B 0.00
Zogenix (ZGNX) United States $2.046B 0.00
Tilray (TLRY) Canada $1.965B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.921B 56.84
Ironwood Pharmaceuticals (IRWD) United States $1.892B 60.33
ChemoCentryx (CCXI) United States $1.704B 0.00
USANA Health Sciences (USNA) United States $1.582B 16.89
Corcept Therapeutics (CORT) United States $1.554B 18.89
Enanta Pharmaceuticals (ENTA) United States $1.252B 28.58
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.233B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.208B 8.24
Endo (ENDP) Ireland $1.132B 2.08
ArQule (ARQL) United States $1.100B 0.00
Karyopharm Therapeutics (KPTI) United States $1.046B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.033B 0.00
Radius Health (RDUS) United States $1.009B 0.00
Aerie Pharmaceuticals (AERI) United States $0.884B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.752B 0.00
Akebia Therapeutics (AKBA) United States $0.722B 0.00
Collegium Pharmaceutical (COLL) United States $0.701B 0.00
Flexion Therapeutics (FLXN) United States $0.697B 0.00
TherapeuticsMD (TXMD) United States $0.640B 0.00
Translate Bio (TBIO) United States $0.600B 0.00
ImmunoGen (IMGN) United States $0.533B 0.00
Ardelyx (ARDX) United States $0.506B 0.00
Organogenesis Holdings (ORGO) United States $0.470B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.470B 57.00
Crinetics Pharmaceuticals (CRNX) United States $0.462B 0.00
Dermira (DERM) United States $0.450B 0.00
Concordia (CXRXF) Canada $0.444B 0.00
Molecular Templates (MTEM) United States $0.441B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.440B 0.00
Harpoon Therapeutics (HARP) United States $0.438B 0.00
DURECT (DRRX) United States $0.423B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.421B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.405B 17.45
Recro Pharma (REPH) United States $0.383B 0.00
Indivior (INVVY) United States $0.379B 1.37
Siga Technologies (SIGA) United States $0.375B 8.57
OptiNose (OPTN) United States $0.374B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.372B 0.00
Lannett Co Inc (LCI) United States $0.357B 4.16
Innate Pharma SA (IPHYF) France $0.339B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.308B 0.00
KalVista Pharmaceuticals (KALV) United States $0.273B 0.00
Rafael Holdings (RFL) United States $0.268B 0.00
GlycoMimetics (GLYC) United States $0.248B 0.00
Calithera Biosciences (CALA) United States $0.241B 0.00
Xeris Pharmaceuticals (XERS) United States $0.238B 0.00
Jounce Therapeutics (JNCE) United States $0.235B 3.14
Matinas Biopharma Holdings (MTNB) United States $0.221B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.221B 0.00
Aquestive Therapeutics (AQST) United States $0.219B 0.00
Ocular Therapeutix (OCUL) United States $0.192B 0.00
Nature's Sunshine Products (NATR) United States $0.190B 32.73
Foamix Pharmaceuticals (FOMX) Israel $0.189B 0.00
Concert Pharmaceuticals (CNCE) United States $0.178B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
MEI Pharma (MEIP) United States $0.144B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.143B 0.00
IMV INC (IMV) Canada $0.141B 0.00
Redhill Biopharma (RDHL) Israel $0.140B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.137B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.120B 0.00
CannTrust Holdings (CTST) Canada $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.106B 0.00
CV Sciences (CVSI) United States $0.104B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.100B 0.00
PolarityTE (PTE) United States $0.084B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Neos Therapeutics (NEOS) United States $0.079B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 23.32
Champions Oncology (CSBR) United States $0.076B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.076B 0.00
Aclaris Therapeutics (ACRS) United States $0.072B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
Capnia (SLNO) United States $0.071B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
SCYNEXIS (SCYX) United States $0.060B 0.00
Genocea Biosciences (GNCA) United States $0.060B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.060B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 0.00
Novan (NOVN) United States $0.056B 0.00
Nivalis Therapeutics (ALPN) United States $0.056B 0.00
CTI BioPharma (CTIC) United States $0.055B 0.00
Natural Alternatives (NAII) United States $0.055B 13.59
Mast Therapeutics (SVRA) United States $0.054B 0.00
Medicure (MCUJF) Canada $0.054B 0.00
RENEURON GP (RNUGF) United Kingdom $0.052B 0.00
AgeX Therapeutics (AGE) United States $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
Iterum Therapeutics (ITRM) Ireland $0.044B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.041B 0.00
IsoRay (ISR) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Opexa Therapeutics (ACER) United States $0.036B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.035B 0.00
Jaguar Animal Health (JAGX) United States $0.034B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Biomerica (BMRA) United States $0.030B 0.00
India Globalization Capital (IGC) United States $0.029B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.025B 0.00
Melinta Therapeutics (MLNT) United States $0.023B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.021B 0.00
Shineco (TYHT) China $0.020B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
Vical (BBI) United States $0.016B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Lipocine (LPCN) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Forward Pharma (FWP) Denmark $0.000B 0.00